510(k) Report

510(k) · Cleared

Cleared

Hydrolyzed Collagen/AG Wound Gel with Silver

K132891510(k) TraditionalCleared Jun 19, 2014276-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

The Hymed Group Corp. · FRO Dressing, Wound, Drug

Cleared on Jun 19, 2014 as substantially equivalent to K073019 (Argentis Biomedical Incorporated, 2008) after a 276-day review. Its family tree reaches back 6 generations to 1997.

Decided
Jun 19, 2014
Review
276 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K973688 (1997). 19 ancestors in all, the oldest K894541 (1989). No later device cites it as a predicate yet.

  1. Root · 6 generations backK973688 Duoderm Control Gel Formula Border DressingConvatec, Ltd. · 1997
  2. 5 generations backK983362 NU-Gel * Wound DressingJohnson & Johnson Medical, Inc. · 1998
  3. 4 generations backK022995 Collatek HydrogelBiocore Medical Technologies, Inc. · 2002
  4. 3 generations backK040019 SilversealNoble Fiber Technologies · 2004
  5. 2 generations backK061227 Hydrolyzed Collagen/AG Wound Gel with SilverThe Hymed Group Corp. · 2006
  6. 1 generation backK073019 Silvermed Antimicrobial Silver HydrogelArgentis Biomedical Incorporated · 2008
  7. This deviceK132891 Hydrolyzed Collagen/AG Wound Gel with SilverThe Hymed Group Corp. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K973688Duoderm Control Gel Formula Border DressingConvatec, Ltd.1997—
−5K983362NU-Gel * Wound DressingJohnson & Johnson Medical, Inc.1998—
−4K022995Collatek HydrogelBiocore Medical Technologies, Inc.2002—
−3K040019SilversealNoble Fiber Technologies2004—
−2K061227Hydrolyzed Collagen/AG Wound Gel with SilverThe Hymed Group Corp.2006—
−1K073019Silvermed Antimicrobial Silver HydrogelArgentis Biomedical Incorporated2008—
0 (this device)K132891Hydrolyzed Collagen/AG Wound Gel with SilverThe Hymed Group Corp.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199310
199410
199610
199810
199930
200130
200610
200710
FIG. 1 — Lineage of K132891, 1997–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K073019Silvermed Antimicrobial Silver Hydrogel
Summary page 1
…available also as an Over-The-Counter (OTC) wound care product substantially equivalent to SilverMed Antinicerobial Wound Gel which was approved for OTC and lix use via K073019. identification of piredicate devices to which substantial equivalence is being claimedan for which approval was srnuted for bot…
Argentis Biomedical Incorporated2008—
†K061227Hydrolyzed Collagen/AG Wound Gel with SilverThe Hymed Group Corp.2006—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 6 companies; a new generation was cleared every 2.4 years on median.
  • None of the 19 ancestors has a recall.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

Indications for Over-the-Counter Use: Hydrolyzed Collagen/Ag Wound Gel is indicated for the management of minor bums, superficial cuts, lacerations, abrasions and minor irritation of the skin.

Indications for Prescription Use: Under the supervision of a healthcare professional, it is indicated for partial and full thickness wounds including pressure ulcers, venous stasis ulcers, diabetic ulcers, first and second degree bums, abrasions, lacerations, skin tears, grafted wounds, donor sites and surgical wounds.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K132891: Hydrolyzed Collagen/AG Wound Gel with Silver.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K132891

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026